US Broker Ratings

Select Medical Holdings Corp (SEM): Investor Outlook Reveals 29.67% Potential Upside in Healthcare Sector

Select Medical Holdings Corporation (NYSE: SEM) stands as a notable player within the healthcare industry, specifically in the realm of medical care facilities. With a market capitalization of $1.74 billion,..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Evaluating Growth Potential Amid Healthcare Innovations

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a prominent player in the healthcare sector, is drawing attention from investors with its innovative approach to managing diabetes. With a market capitalization of..

Ascentage Pharma Group International (AAPG): Valuation Insights Reveal Significant Potential Upside for Investors

Ascentage Pharma Group International (AAPG) is making waves in the biotechnology sector with its innovative approach to developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases. Headquartered..

Omnicell, Inc. (OMCL) Investor Outlook: Evaluating a 30.61% Upside in the Healthcare Automation Space

Omnicell, Inc. (NASDAQ: OMCL), a key player in the healthcare automation sector, has captured the attention of investors with its robust portfolio of medication management solutions and a promising potential..

Edgewise Therapeutics (EWTX) Stock Analysis: Unraveling the 62.55% Potential Upside

For investors with an eye on the biotechnology sector, Edgewise Therapeutics, Inc. (NASDAQ: EWTX) presents an intriguing opportunity. With a market capitalization of $2.49 billion, this Boulder, Colorado-based biopharmaceutical company..

NewAmsterdam Pharma (NAMS) Investor Outlook: Promising Upside Amid Biotech Challenges

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) is a noteworthy player in the biotech sector, capturing investor attention with its promising pipeline targeting metabolic diseases. Headquartered in Naarden, the Netherlands, this..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Unveiling a 60% Upside Potential in Biotechnology

Dyne Therapeutics, Inc. (NASDAQ: DYN), a clinical-stage company headquartered in Waltham, Massachusetts, is making waves in the biotechnology sector with its innovative approach to treating neuromuscular diseases. Specializing in a..

PACS Group, Inc. (PACS)

⚠️ No article content returned.

..

GRAIL, Inc. (GRAL): Investor Outlook on a High-Stakes Healthcare Innovator

GRAIL, Inc. (NASDAQ: GRAL) is at the forefront of the healthcare sector, specifically within the diagnostics and research industry. Based in Menlo Park, California, GRAIL is known for its groundbreaking..

CRISPR Therapeutics AG (CRSP) Stock Analysis: 59% Potential Upside Amid Rapid Revenue Growth

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering entity in the biotechnology sector, has been making waves with its groundbreaking work in gene editing. Headquartered in Zug, Switzerland, the company has..

AtriCure, Inc. (ATRC) Stock Analysis: Exploring a 36.9% Potential Upside for Investors

AtriCure, Inc. (NASDAQ: ATRC) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Mason, Ohio, AtriCure specializes in the development..

Mesoblast Limited (MESO) Stock Analysis: Exploring a 124% Potential Upside in the Biotechnology Arena

Investors with an eye on the healthcare sector might find Mesoblast Limited (NASDAQ: MESO) intriguing, especially given its substantial growth potential. The Melbourne-based biotechnology company, known for its pioneering work..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Impressive Revenue Growth Amidst High Forward P/E

Arcutis Biotherapeutics, Inc. (ARQT) is making waves in the biotechnology sector with its focus on innovative treatments for dermatological diseases. Based in Westlake Village, California, this U.S.-based company has captured..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: A 15.12% Potential Upside in the Healthcare Sector

Alphatec Holdings, Inc. (NYSE: ATEC), a prominent player in the medical devices industry, specializes in innovative technologies for the surgical treatment of spinal disorders. With a market capitalization of $3.06..

National HealthCare Corporation (NHC) Stock Analysis: A Steady Performer with 12.5% Revenue Growth in the Healthcare Sector

National HealthCare Corporation (NYSE: NHC) has established itself as a prominent player in the healthcare sector, specializing in medical care facilities across the United States. With a market capitalization of..

Denali Therapeutics (DNLI) Stock Analysis: A 69% Potential Upside in Neurodegenerative Treatment Innovations

Denali Therapeutics Inc. (NASDAQ: DNLI) is capturing the attention of investors with its innovative approach to treating neurodegenerative and lysosomal storage diseases. With a market capitalization of $2.78 billion, this..

LivaNova PLC (LIVN) Stock Analysis: Exploring a 14.29% Upside Amidst Strong Revenue Growth

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, is garnering attention from investors due to its notable position in the medical devices industry. Headquartered in London, LivaNova’s..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring 144.79% Potential Upside in Biotech Innovation

Investors seeking opportunities within the burgeoning biotech sector might find Janux Therapeutics, Inc. (NASDAQ: JANX) particularly compelling. With a market capitalization of $1.9 billion, Janux is making strides in the..

HUTCHMED (China) Limited (HCM) Investor Outlook: Unpacking a 58.53% Potential Upside

HUTCHMED (China) Limited (HCM) represents a compelling opportunity for investors interested in the dynamic field of biotechnology and pharmaceuticals. With its specialization in developing and commercializing targeted therapeutics and immunotherapies,..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Exploring a Promising 13% Upside Potential in Biotechnology

In the dynamic world of biotechnology, Scholar Rock Holding Corporation (NASDAQ: SRRK) presents an intriguing opportunity for investors focused on innovation-driven growth. With a market capitalization of $4.26 billion, this..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds